SCHEMBL25152807

SCHEMBL25152807

CN(Cc1ccccc1)[C@H](CNCc1ccccc1)Cc1ccc(C(N)=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 12/20 0.57
OPRD1 P41143 11/20 0.57
OPRM1 P35372 6/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PLA2G10 O15496 1/20 0.44
PLA2G2A P14555 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
RORC P51449 1/20 0.42
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2A P28223 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25152778 0.84 PLA2G10 (0.50) OPRK1OPRD1OPRM1MEN1KMT2A
SCHEMBL6318879 0.78 OPRK1 (0.56) OPRK1OPRD1OPRM1ALDH1A1LMNA
SCHEMBL27487738 0.78 OPRK1 (0.56) OPRK1OPRD1OPRM1ALDH1A1LMNA
SCHEMBL16709791 0.76 PLA2G10 (0.69) OPRK1OPRD1OPRM1PLA2G10PLA2G2A
SCHEMBL25152370 0.73 OPRM1 (0.67) OPRK1OPRD1OPRM1ALDH1A1LMNA
SCHEMBL23405295 0.72 OPRM1 (0.77) OPRK1OPRD1OPRM1
SCHEMBL28569460 0.72 OPRM1 (0.54) OPRK1OPRD1OPRM1ALDH1A1LMNA
SCHEMBL28569463 0.72 OPRM1 (0.54) OPRK1OPRD1OPRM1ALDH1A1LMNA
SCHEMBL271176 0.72 ATM (0.51) OPRK1OPRD1OPRM1ALDH1A1LMNA
SCHEMBL18232484 0.72 OPRM1 (0.56) OPRK1OPRD1OPRM1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634396-B2 Opioid receptor modulators EPIODYNE, INC. (US) 2023-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634396-B2 Opioid receptor modulators OPRM1, OPRK1, OPRL1 OPRK1 2/4885OPRD1 4/4885OPRM1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.